April 20, 2017

Genovis AB publish Annual Report 2016

Regulatory
Genovis’ 2016 Annual Report is from today available at our website www.genovis.com. The English version of the annual report is expected to be published shortly.

The printed Annual Report can be ordered from the company: 

Telephone +46 (0)46-10 12 30  

E-mail info@genovis.com 

For more information, please contact: Fredrik Olsson, CEO, Genovis AB Tel: 0046 (0)46 -101233 fredrik.olsson@genovis.com


ABOUT GENOVIS

Genovis is a global company that offers enzyme products that facilitate development and quality control of biologics to customers in the pharmaceutical and medical technology industries. The Company markets several enzyme products (“SmartEnzymes”) in innovative product formats all over the world.

The organization consists of Genovis AB and the wholly owned subsidiary Genovis Inc. in the US. Genovis Inc. handles all sales of enzyme products on the North American market and Genovis AB handles sales in the rest of the world. Genovis shares are listed on Nasdaq First North Stockholm and Penser Bank is the Company’s Certified Adviser, t: 46(0) 8 463 83 00.

This press release is a translation of the Swedish original. In the event of any discrepancy between this translation and the Swedish original, the Swedish version shall prevail.


Release
  • Svenska